| Term 
 
        | pt can learn but wont remember unless prompted: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | impaired learning and won't remember even when prompted: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | beta amyloid plaques W/O neurfibrillary tangles: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | dementia with extrapyramidal motor symptoms |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | visual spacial (drawing) and calculation spared |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | visual spacial (drawing) and calculation ability hindered: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AChEi: SE is hepatotox largely replaced by safer meds |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | topical patch available may help w GI side effects: |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks the action of excitatory nt glutamate. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. CNS 2. GI
 3. CV
 agitation, dysrrhythmias, tachy, HTN, constipation
 |  | 
        |  | 
        
        | Term 
 
        | therapy for cognitive sx but reserved for severe dz: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | conditions medications that increase the risk for delirium: |  | Definition 
 
        | D - drugs E - eyes/ears
 L - low O2
 I - infection
 R - retention
 I - ictal
 U - underhydrated/nutrition
 M - metabolic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. AD (sep TCAs) 2. Antipsychotics
 3. DA
 4. opiods
 5. BZO
 6. corticosteroids
 7. Lithium
 8. EtOH withdrawal
 9. anticholinergics
 |  | 
        |  | 
        
        | Term 
 
        | antipsychotic causes agranulocytosis: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5 risks w chronic antipsychotic use: |  | Definition 
 
        | 1. sedation 2. anticholinergic effects
 3. CV
 4. dyskinesias
 5. risk of sudden death doubles
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. HA 2. N/V/D
 3. anxiety
 4. serotonin syndrome
 5. increasd risk of suicide in the elderly during the first month of therapy
 |  | 
        |  | 
        
        | Term 
 
        | serotonin syndrome triad: |  | Definition 
 
        | 1. cognitive effects 2. autonomic effects (sweating, HTN)
 3. somatic effects (myoclonua, hyperreflexia, tremor)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. paxil 2. prozac
 3. effexor
 4. remeron
 |  | 
        |  | 
        
        | Term 
 
        | SSRI: most likely to raise BP |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SSRI: higher sedation at lower doses |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SSRI: long 1/2 life; may accumulate in elderly |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SSRI: high anti-chol effects |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. anterograde amnesia 2. paradoxical agitation
 3. sedation
 |  | 
        |  |